177 related articles for article (PubMed ID: 26481178)
1. Treatment and Survival Trends in Glottic Carcinoma in Situ and Stage I Cancer From 1988 to 2012.
Khaja SF; Hoffman HT; Pagedar NA
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):311-6. PubMed ID: 26481178
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, functional outcome, and costs of early glottic cancer.
Smith JC; Johnson JT; Cognetti DM; Landsittel DP; Gooding WE; Cano ER; Myers EN
Laryngoscope; 2003 Jan; 113(1):68-76. PubMed ID: 12514385
[TBL] [Abstract][Full Text] [Related]
3. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
[No Abstract] [Full Text] [Related]
4. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
[TBL] [Abstract][Full Text] [Related]
5. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
7. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
9. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.
Beyaert S; Hamoir M; Van Maanen A; Grégoire V; Schmitz S
Eur J Surg Oncol; 2019 Jul; 45(7):1188-1195. PubMed ID: 30940421
[TBL] [Abstract][Full Text] [Related]
11. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
12. [A Clinical Study of 109 Cases of Glottic Squamous Cell Carcinoma].
Sagawa K; Terada T; Uwa N; Mohri T; Sakagami M
Nihon Jibiinkoka Gakkai Kaiho; 2015 Jun; 118(6):751-6. PubMed ID: 26336748
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prognosis of stage IV glottic laryngeal cancer].
Lai FY; Zhang Q; Guo ZM; Zeng ZY; Li H; Yu WB; Yang CS
Ai Zheng; 2008 Jan; 27(1):71-4. PubMed ID: 18184468
[TBL] [Abstract][Full Text] [Related]
14. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
15. T1-2 glottic cancer treated with radiotherapy and/or surgery.
Shelan M; Anschuetz L; Schubert AD; Bojaxhiu B; Dal Pra A; Behrensmeier F; Aebersold DM; Giger R; Elicin O
Strahlenther Onkol; 2017 Dec; 193(12):995-1004. PubMed ID: 28474090
[TBL] [Abstract][Full Text] [Related]
16. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
Pham TA; De Freitas R; Sigston E; Vallance N
ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
[TBL] [Abstract][Full Text] [Related]
17. Supracricoid partial laryngectomy with crico-hyoido-epiglottopexy for glottic carcinoma with anterior commissure involvement.
Atallah I; Berta E; Coffre A; Villa J; Reyt E; Righini CA
Acta Otorhinolaryngol Ital; 2017 Jun; 37(3):188-194. PubMed ID: 28516961
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
[TBL] [Abstract][Full Text] [Related]
20. Surgery versus radiation for T1 glottic carcinoma: Second primary considerations.
Puram SV; Bhattacharyya N
Laryngoscope; 2019 Dec; 129(12):2713-2715. PubMed ID: 30767222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
